Tag: real world evidence

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Real World Evidence Solutions Market Increase Between 2026 And 2030?

The real world evidence solutions market has experienced rapid expansion in recent years. It is projected to increase from $2.33 billion in 2025 to $2.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. This historical growth can be ascribed to several factors, including the rising availability of real-world healthcare data, an increased demand for post-approval evidence, a greater emphasis on drug safety monitoring, the broader adoption of electronic health records, and the early regulatory acceptance of RWE.

The real world evidence solutions market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.6%. Factors driving this expansion during the forecast period include regulatory decisions becoming more data-driven, the expanding application of RWE in reimbursement choices, the proliferation of precision medicine programs, the greater incorporation of real-time healthcare information, and the increasing uptake of AI-powered evidence platforms. Key trends predicted for the forecast period encompass a greater deployment of advanced analytics within RWE research, the growing merging of EHR and claims data, the increasing implementation of AI-led evidence generation, the broader application of RWE in regulatory filings, and a heightened emphasis on monitoring post-market safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

What Are The Main Drivers Accelerating The Growth Of The Real World Evidence Solutions Market?

An expanding geriatric demographic is anticipated to fuel the growth of the real-world evidence solutions market. This population segment, consisting of individuals aged 65 and older, faces an elevated risk of falls due to various reasons, including postural hypotension, and balance or gait impairment. Aging also heightens the susceptibility to chronic diseases such as strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For instance, data published in January 2024 by the US-based nonprofit organization, Population Reference Bureau, projects that the population of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to rise from 17% to 23%. Consequently, the increasing geriatric population is a primary driver for the expansion of the real-world evidence solutions market.

What Segment Categories Are Evaluated In The Real World Evidence Solutions Market Study?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

What Trends Are Driving Changes In The Real World Evidence Solutions Market?

Leading companies within the real time health monitoring devices market are concentrating on developing sophisticated solutions that leverage innovative technologies, such as advanced sensing technology, to achieve a competitive advantage in the market. Advanced sensing technology is a technology that allows real-time health monitoring devices to deliver precise and accurate measurements of vital signs and health parameters. For instance, in April 2023, Honeywell, a US-based electrical and electronics manufacturing company, unveiled a real-time health monitoring system (RTHMS). The RTHMS functions as an intelligent interface connecting patients and caregivers, integrating both hardware and software to improve care delivery, enhance the efficiency of healthcare workers, and streamline various processes. This system, designed for perpetual patient connection, alerts physicians to changes in patients’ vital signs and substantially reduces the duration needed to collect, analyze, and apply patient data as actionable insights. The remote monitoring system, which incorporates advanced sensing technology, has the capacity to alleviate clinician workloads and potentially save many hours previously spent on error-prone administrative duties by automating critical operations.

Which Industry Players Are Present In The Real World Evidence Solutions Market?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Access The Complete Real World Evidence Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

Which Region Is The Dominant Market In The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Real World Evidence Solutions Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=6930&type=smp

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market 2026

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Real World Evidence Solutions Market Expected To Reach Based On Its 2026 Value?

The real world evidence solutions market has experienced rapid expansion in its size over recent years. Projections indicate its value will increase from $2.33 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. Historically, this growth stemmed from factors such as the increasing availability of real-world healthcare data, a heightened demand for post-approval evidence, an expanding emphasis on drug safety monitoring, the broader adoption of electronic health records, and the early regulatory acceptance of RWE.

The real world evidence solutions market is anticipated to undergo significant expansion in the coming years. It is projected to attain a market size of $4.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.6%. This growth during the forecast period can be attributed to factors such as data-driven regulatory decision-making, the expanding application of RWE in reimbursement decisions, the proliferation of precision medicine initiatives, the increasing integration of real-time healthcare data, and the rising adoption of AI-enabled evidence platforms. Noteworthy trends anticipated for this period involve a greater utilization of advanced analytics in RWE studies, the increasing integration of EHR and claims data, a growing embrace of AI-driven evidence generation, the broader application of RWE in regulatory submissions, and an enhanced focus on post-market safety monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

Which Primary Drivers Are Impacting The Real World Evidence Solutions Market Growth?

The expanding geriatric population is expected to significantly boost the real-world evidence solutions market. This demographic, comprising individuals aged 65 and above, faces an elevated risk of falls due to factors such as postural hypotension and impairments in balance or gait. Furthermore, aging heightens the prevalence of chronic illnesses like strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For example, in January 2024, as per figures released by the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% growth. Moreover, their representation within the overall population is expected to climb from 17% to 23%. Thus, the increasing geriatric demographic is a key driver for the real-world evidence solutions market’s expansion.

What Segment Categories Shape The Real World Evidence Solutions Market Segment Landscape?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

Which Trends Are Shaping Growth In The Real World Evidence Solutions Market?

Key companies active in the real-world evidence solutions market are pioneering innovative offerings, including a novel real-world evidence (RWE) solutions service, aimed at optimizing evidence-based medicine. These services are engineered to produce and assess clinical evidence regarding the use, prospective advantages, and dangers of medical products, leveraging real-world data (RWD) obtained from standard healthcare operations. As an illustration, in October 2023, Maxis Clinical Sciences, a US-based clinical research consultancy assisting small to medium-sized pharmaceutical and life sciences firms globally, unveiled its new Real-World Evidence (RWE) Solutions service. The RWE Solutions from Maxis Clinical Sciences was established to integrate multiple RWD sources. These encompass patient-reported outcomes and data from wearable devices, strategically designed to enhance patient engagement and data quality.

Who Are The Companies Operating Across The Real World Evidence Solutions Market Value Chain?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Get The Full Real World Evidence Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

Which Geographic Region Dominates The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Real World Evidence Solutions Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Real World Evidence Solutions Market Evolve From 2026 To 2030?

The real world evidence solutions market size has seen swift expansion in recent years. It is anticipated to expand from $2.33 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be ascribed to several factors, including the increasing accessibility of real-world healthcare data, a growing need for post-approval evidence, a heightened emphasis on drug safety monitoring, the wider adoption of electronic health records, and the initial regulatory acceptance of RWE.

The market for real world evidence solutions is projected to experience substantial expansion in the coming years. Its valuation is set to reach $4.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This projected growth is primarily fueled by factors such as data-driven regulatory decision-making, the increasing application of real-world evidence (RWE) in reimbursement determinations, the broadening scope of precision medicine initiatives, the enhanced integration of real-time healthcare data, and the rising uptake of AI-powered evidence platforms. Key developments anticipated during this period encompass a greater utilization of advanced analytics in RWE research, the expanding integration of electronic health records (EHR) and claims data, the heightened adoption of AI-driven evidence generation, the wider incorporation of RWE into regulatory submissions, and an intensified focus on monitoring post-market safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Real World Evidence Solutions Market?

The expansion of the elderly demographic is anticipated to stimulate the growth of the real-world evidence solutions market. This demographic includes individuals aged 65 and above, who face an elevated susceptibility to falls due to factors like postural hypotension, along with balance or gait difficulties. Furthermore, advancing age heightens the likelihood of developing chronic conditions such as strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For example, data released in January 2024 by the US-based nonprofit organization, the Population Reference Bureau, indicated that the number of Americans aged 65 and older is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Concurrently, their proportion of the overall population is forecasted to increase from 17% to 23%. Consequently, the increasing geriatric population is fueling the expansion of the real-world evidence solutions market.

Which Segment Areas Are Covered In The Real World Evidence Solutions Market Analysis?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

What Trends Are Advancing Progress In The Real World Evidence Solutions Market?

Leading companies in the real-world evidence solutions market are developing innovative offerings, such as a new real-world evidence (RWE) solutions service, intended to optimize evidence-based medicine. These RWE solutions services are created to generate and analyze clinical evidence concerning the usage, potential benefits, and risks of medical products, utilizing real-world data (RWD) that originates from routine healthcare delivery. For example, in October 2023, Maxis Clinical Sciences, a US-based clinical research consultancy assisting small to medium-sized pharmaceutical and life sciences companies globally, introduced its new Real-World Evidence (RWE) Solutions service. Maxis Clinical Sciences’ RWE Solutions was established to combine multiple RWD sources, including patient-reported outcomes and data from wearable devices, specifically designed to enhance patient participation and data quality.

Which Global Companies Are Actively Competing In The Real World Evidence Solutions Market?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Read the full real world evidence solutions market report here:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

What Are The Leading Geographic Regions In The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real World Evidence Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6930&type=smp

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Real World Evidence Solutions Market Evolve From 2026 To 2030?

The real world evidence solutions market size has seen swift expansion in recent years. It is anticipated to expand from $2.33 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be ascribed to several factors, including the increasing accessibility of real-world healthcare data, a growing need for post-approval evidence, a heightened emphasis on drug safety monitoring, the wider adoption of electronic health records, and the initial regulatory acceptance of RWE.

The market for real world evidence solutions is projected to experience substantial expansion in the coming years. Its valuation is set to reach $4.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This projected growth is primarily fueled by factors such as data-driven regulatory decision-making, the increasing application of real-world evidence (RWE) in reimbursement determinations, the broadening scope of precision medicine initiatives, the enhanced integration of real-time healthcare data, and the rising uptake of AI-powered evidence platforms. Key developments anticipated during this period encompass a greater utilization of advanced analytics in RWE research, the expanding integration of electronic health records (EHR) and claims data, the heightened adoption of AI-driven evidence generation, the wider incorporation of RWE into regulatory submissions, and an intensified focus on monitoring post-market safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Real World Evidence Solutions Market?

The expansion of the elderly demographic is anticipated to stimulate the growth of the real-world evidence solutions market. This demographic includes individuals aged 65 and above, who face an elevated susceptibility to falls due to factors like postural hypotension, along with balance or gait difficulties. Furthermore, advancing age heightens the likelihood of developing chronic conditions such as strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For example, data released in January 2024 by the US-based nonprofit organization, the Population Reference Bureau, indicated that the number of Americans aged 65 and older is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Concurrently, their proportion of the overall population is forecasted to increase from 17% to 23%. Consequently, the increasing geriatric population is fueling the expansion of the real-world evidence solutions market.

Which Segment Areas Are Covered In The Real World Evidence Solutions Market Analysis?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

What Trends Are Advancing Progress In The Real World Evidence Solutions Market?

Leading companies in the real-world evidence solutions market are developing innovative offerings, such as a new real-world evidence (RWE) solutions service, intended to optimize evidence-based medicine. These RWE solutions services are created to generate and analyze clinical evidence concerning the usage, potential benefits, and risks of medical products, utilizing real-world data (RWD) that originates from routine healthcare delivery. For example, in October 2023, Maxis Clinical Sciences, a US-based clinical research consultancy assisting small to medium-sized pharmaceutical and life sciences companies globally, introduced its new Real-World Evidence (RWE) Solutions service. Maxis Clinical Sciences’ RWE Solutions was established to combine multiple RWD sources, including patient-reported outcomes and data from wearable devices, specifically designed to enhance patient participation and data quality.

Which Global Companies Are Actively Competing In The Real World Evidence Solutions Market?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Read the full real world evidence solutions market report here:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

What Are The Leading Geographic Regions In The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real World Evidence Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6930&type=smp

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Real World Evidence Solutions Market Evolve From 2026 To 2030?

The real world evidence solutions market size has seen swift expansion in recent years. It is anticipated to expand from $2.33 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be ascribed to several factors, including the increasing accessibility of real-world healthcare data, a growing need for post-approval evidence, a heightened emphasis on drug safety monitoring, the wider adoption of electronic health records, and the initial regulatory acceptance of RWE.

The market for real world evidence solutions is projected to experience substantial expansion in the coming years. Its valuation is set to reach $4.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This projected growth is primarily fueled by factors such as data-driven regulatory decision-making, the increasing application of real-world evidence (RWE) in reimbursement determinations, the broadening scope of precision medicine initiatives, the enhanced integration of real-time healthcare data, and the rising uptake of AI-powered evidence platforms. Key developments anticipated during this period encompass a greater utilization of advanced analytics in RWE research, the expanding integration of electronic health records (EHR) and claims data, the heightened adoption of AI-driven evidence generation, the wider incorporation of RWE into regulatory submissions, and an intensified focus on monitoring post-market safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Real World Evidence Solutions Market?

The expansion of the elderly demographic is anticipated to stimulate the growth of the real-world evidence solutions market. This demographic includes individuals aged 65 and above, who face an elevated susceptibility to falls due to factors like postural hypotension, along with balance or gait difficulties. Furthermore, advancing age heightens the likelihood of developing chronic conditions such as strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For example, data released in January 2024 by the US-based nonprofit organization, the Population Reference Bureau, indicated that the number of Americans aged 65 and older is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Concurrently, their proportion of the overall population is forecasted to increase from 17% to 23%. Consequently, the increasing geriatric population is fueling the expansion of the real-world evidence solutions market.

Which Segment Areas Are Covered In The Real World Evidence Solutions Market Analysis?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

What Trends Are Advancing Progress In The Real World Evidence Solutions Market?

Leading companies in the real-world evidence solutions market are developing innovative offerings, such as a new real-world evidence (RWE) solutions service, intended to optimize evidence-based medicine. These RWE solutions services are created to generate and analyze clinical evidence concerning the usage, potential benefits, and risks of medical products, utilizing real-world data (RWD) that originates from routine healthcare delivery. For example, in October 2023, Maxis Clinical Sciences, a US-based clinical research consultancy assisting small to medium-sized pharmaceutical and life sciences companies globally, introduced its new Real-World Evidence (RWE) Solutions service. Maxis Clinical Sciences’ RWE Solutions was established to combine multiple RWD sources, including patient-reported outcomes and data from wearable devices, specifically designed to enhance patient participation and data quality.

Which Global Companies Are Actively Competing In The Real World Evidence Solutions Market?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Read the full real world evidence solutions market report here:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

What Are The Leading Geographic Regions In The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real World Evidence Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6930&type=smp

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model